NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Subjects United States Remove constraint Subjects: United States

Search Results

8. State Pharmacy Assistance Programs vs. Medicare prescription drug plans: how do they contain rising costs?

9. Understanding workers' compensation medical care in California

14. Telemedicine in California: progress, challenges, and opportunities

15. Scope of practice laws in health care: rethinking the role of nurse practitioners

16. Scope of practice laws in health care: exploring new approaches for California

17. An unprecedented opportunity: using federal stimulus funds to advance health IT in California

18. Using tracking tools to improve patient flow in hospitals

19. Trendspotting: how IT triggers better care in nursing homes

20. Shifting ground: erosion of the delegated model in California

21. A tighter bond: California hospitals seek stronger ties with physicians

22. Weaving palliative care into primary care: a guide for community health centers

23. Data inadequacies undermine CMS's oversight of the inconsistency resolution process for the federal marketplace

24. CMS validated hospital inpatient quality reporting program data, but should use additional tools to identify gaming

26. CDC generally met its inspection goals for the federal select agent program: however, opportunities exist to strengthen oversight

28. Round 2 competitive bidding for CPAP/RAD: disrupted access unlikely for devices, inconclusive for supplies

30. OHRP generally conducted its compliance activities independently, but changes would strengthen its independence

31. HHS's Office of Refugee Resettlement improved coordination and outreach to promote the safety and well-being of unaccompanied alien children

32. Medicare program shared savings accountable care organizations have shown potential for reducing spending and improving quality

35. As funding for BPA research increased, NIEHS followed its peer review process while also exercising its discretion

37. Medicare Part B drug payments: impact of price substitutions based on 2014 average sales prices

39. Drug supply chain security: wholesalers exchange most tracing information

44. Enhancements needed in the tracking and collection of Medicare overpayments identified by ZPICS and PSCS

45. A few states fell short in timely investigation of the most serious nursing home complaints: 2011-2015

47. Medicare Part B drug payments: impact of price substitutions based on 2015 average sales prices

48. Medicare payments for clinical diagnostic laboratory tests in 2016: year 3 of baseline data

49. Excluding noncovered versions when setting payment for two Part B drugs would have resulted in lower drug costs for Medicare and its beneficiaries

50. Medicaid Fraud Control Units: investigation and prosecution of fraud and beneficiary abuse in Medicaid personal care services

51. Followup review: CMS's management of the quality payment program

52. Potential misclassifications reported by drug manufacturers may have led to $1 billion in lost Medicaid rebates

53. Entities' experiences and perceptions of reporting the theft, loss, or release of select agents or toxins to CDC

54. Drug supply chain security: dispensers received most tracing information

56. Round two competitive bidding for oxygen: continued access for vast majority of beneficiaries

57. Round two competitive bidding for enteral nutrition: continued access for vast majority of beneficiaries

58. HRSA helped health centers with elevated risks and can continue to take additional steps

60. Part D plans generally include drugs commonly used by dual eligibles: 2018

62. Entities generally met Federal Select Agent Program internal inspection requirements, but CDC could do more to improve effectiveness

63. Opioid use in Medicare Part D remains concerning

64. CMS did not detect some inappropriate claims for durable medical equipment in nursing facilities

65. Opioids in Ohio Medicaid: review of extreme use and prescribing

68. Medicare Part B drug payments: impact of price substitutions based on 2016 average sales prices

69. Questionable billing for compounded topical drugs in Medicare Part D

70. FDA should further integrate its review of cybersecurity into the premarket review process for medical devices

71. Treatment planning and medication monitoring were lacking for children in foster care receiving psychotropic medication

72. Medicare payments for clinical diagnostic laboratory tests in 2017: year 4 of baseline data

76. Medicare Advantage appeal outcomes and audit findings raise concerns about service and payment denials

77. States follow a common framework in responding to breaches of Medicaid data

78. Hospitals reported improved preparedness for emerging infectious diseases after the Ebola outbreak

79. What is “affordable” health care?: a review of concepts to guide policymakers

80. A comprehensive measure of the costs of caring for a parent: differences according to functional status

82. The cost of employer insurance is a growing burden for middle-income families

83. Study of the impact of the ACA implementation in Kentucky: semi-annual report : baseline data for the implementation of the Affordable Care Act in Kentucky

84. Study of the impact of the ACA implementation in Kentucky: ACA improves health insurance coverage for Kentucky children

85. Evaluation of the Minnesota Accountable Health Model: first annual report : final

86. Study of the impact of the ACA implementation in Kentucky: section 1115 waivers and ACA Medicaid expansions : a review of policies and evidence from five states

87. Study of the impact of the ACA implementation in Kentucky: semi-annual report

88. SIM "stack" in Minnesota: a case study of Otter Tail County Public Health

89. Study of the impact of the ACA implementation in Kentucky: final report

90. Evaluation of the Minnesota accountable health model: executive summary

91. Section 1115 Medicaid expansion waivers: implementation experiences : findings from structured interviews in Arkansas, Indiana, Iowa, & Michigan : final report

92. Minnesota's uninsured in 2017: rates and characteristics

93. Minnesota's accountable communities for health: context and core components

94. The opioid epidemic: national trends in opioid-related overdose deaths from 2000 to 2016

95. The opioid epidemic: state trends in opioid-related overdose deaths from 2000 to 2016

96. State level trends in children's health insurance coverage, 2016: 50-state comparison tables

97. Comparing federal government surveys that count the uninsured: 2018

98. How ACOs are caring for people with complex needs

99. What is the status of women's health and health care in the U.S. compared to ten other countries?

100. Cost impact of the transitional care model for hospitalized cognitively impaired older adults: use of advanced practice nurses can lower postacute care use and costs